Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Eradication of Helicobacter Pylori According to 23S rRNA Point Mutations Associated With Clarithromycin Resistance

NCT01453036 is registered in ClinicalTrials.gov with Jin Il Kim as lead sponsor.

NCT NCT01453036
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01453036 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Eradication of Helicobacter Pylori According to 23S rRNA Point Mutations Associated With Clarithromycin Resistance
Lead sponsor
Jin Il Kim
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2011
Completion date
June 30, 2012
Enrollment
924 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

helicobacter pylori infection, peptic ulcer